Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Nonmelanomatous Skin Cancer Global Clinical Trials Review, H2, 2013
  • USA - English


News provided by

Research Advisor at Reportbuyer.com

Oct 24, 2013, 13:10 ET

Share this article

Share toX

Share this article

Share toX

(PRWEB) October 24, 2013 -- Summary

GlobalData's clinical trial report, “Nonmelanomatous Skin Cancer Global Clinical Trials Review, H2, 2013" provides data on the Nonmelanomatous Skin Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nonmelanomatous Skin Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Nonmelanomatous Skin Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

-Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
-Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
-Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

-Understand the dynamics of a particular indication in a condensed manner
-Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
-Obtain discontinued trial listing for trials across the globe
-Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Nonmelanomatous Skin Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Nations 13
Clinical Trials in G7 Nations by Trial Status 14
Clinical Trials by Phase 15
In Progress Trials by Phase 16
Clinical Trials by Trial Status 17
Unaccomplished Trials of Nonmelanomatous Skin Cancer 18
Subjects Recruited Over a Period of Time 20
Prominent Sponsors 21
Top Companies Participating in Nonmelanomatous Skin Cancer Therapeutics Clinical Trials 22
Prominent Drug Comparison 23
Clinical Trial Profiles 24
Clinical Trial Overview of Top Companies 24
ZBC Multicare 24
Clinical Trial Overview of ZBC Multicare 24
PharmaQest Pty. Ltd. 25
Clinical Trial Overview of PharmaQest Pty. Ltd. 25
Genextra S.p.a. 26
Clinical Trial Overview of Genextra S.p.a. 26
Healthpoint Biotherapeutics 27
Clinical Trial Overview of Healthpoint Biotherapeutics 27
Pfizer Inc. 28
Clinical Trial Overview of Pfizer Inc. 28
Galderma S.A. 29
Clinical Trial Overview of Galderma S.A. 29
Clinical Trial Overview of Top Institutes / Government 30
National Cancer Institute 30
Clinical Trial Overview of National Cancer Institute 30
Roswell Park Cancer Institute 31
Clinical Trial Overview of Roswell Park Cancer Institute 31
The University of Arizona 32
Clinical Trial Overview of The University of Arizona 32
The University of Sydney 33
Clinical Trial Overview of The University of Sydney 33
The University of Chicago 34
Clinical Trial Overview of The University of Chicago 34
The Cleveland Clinic 35
Clinical Trial Overview of The Cleveland Clinic 35
Baylor College of Medicine 36
Clinical Trial Overview of Baylor College of Medicine 36
North Central Cancer Treatment Group 37
Clinical Trial Overview of North Central Cancer Treatment Group 37
The Medical University of Graz 38
Clinical Trial Overview of The Medical University of Graz 38
Northwestern University 39
Clinical Trial Overview of Northwestern University 39
University of Massachusetts 40
Clinical Trial Overview of University of Massachusetts 40
Case Comprehensive Cancer Center 41
Clinical Trial Overview of Case Comprehensive Cancer Center 41
Oregon Health and Science University 42
Clinical Trial Overview of Oregon Health and Science University 42
Rigshospitalet 43
Clinical Trial Overview of Rigshospitalet 43
University of California, San Diego 44
Clinical Trial Overview of University of California, San Diego 44
Massachusetts General Hospital 45
Clinical Trial Overview of Massachusetts General Hospital 45
National Institute of Arthritis and Musculoskeletal and Skin Diseases 46
Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 46
University of Alabama at Birmingham 47
Clinical Trial Overview of University of Alabama at Birmingham 47
University of Wisconsin Madison 48
Clinical Trial Overview of University of Wisconsin Madison 48
University of California, Irvine 49
Clinical Trial Overview of University of California, Irvine 49
Five Key Clinical Profiles 50
Appendix 69
Abbreviations 69
Definitions 69
Research Methodology 70
Secondary Research 70
About GlobalData 71
Contact Us 71
Disclaimer 71
Source 72

1.1 List of Tables

Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2013* 10
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, G7 Countries, 2013* 13
Nonmelanomatous Skin Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 14
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2013* 15
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 16
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 17
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 18
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2013* 19
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 20
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 21
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 22
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 23
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ZBC Multicare, 2013* 24
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by PharmaQest Pty. Ltd., 2013* 25
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Genextra S.p.a., 2013* 26
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Healthpoint Biotherapeutics, 2013* 27
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 28
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Galderma S.A., 2013* 29
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2013* 30
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2013* 31
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Arizona, 2013* 32
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Sydney, 2013* 33
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2013* 34
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2013* 35
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2013* 36
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by North Central Cancer Treatment Group, 2013* 37
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical University of Graz, 2013* 38
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2013* 39
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2013* 40
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2013* 41
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2013* 42
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2013* 43
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2013* 44
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2013* 45
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2013* 46
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2013* 47
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2013* 48
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Irvine, 2013* 49

List of Figures

Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2013* 10
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, G7 Countries (%), 2013* 13
Nonmelanomatous Skin Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 14
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 15
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 16
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 17
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 20
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 21
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 22
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 23
GlobalData Methodology 70

Read the full report:

Nonmelanomatous Skin Cancer Global Clinical Trials Review, H2, 2013

http://www.reportbuyer.com/pharma_healthcare/treatments/nonmelanomatous_skin_cancer_global_clinical_trials_review_h2_2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: http://www.reportbuyer.com/

Sarah Smith, Research Advisor at Reportbuyer.com, +44 208 816 85 48, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.